This inventor holds 1 USPTO granted patent. Top assignee: New York University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Alan B Frey: Innovator in Immunology
Introduction
Alan B Frey is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of immunology, particularly through his innovative patent work. His research focuses on the modulation of T cell effector function, which is crucial for developing effective cancer therapies.
Latest Patents
Alan B Frey holds a patent titled "Methods and agents for modulating protocadherin-18 activity." This patent describes screening assays and methods for identifying modulator agents or compounds that affect protocadherin-18 (pcdh18) mediated inhibition of T cell effector function. The patent encompasses pharmaceutical and immunogenic compositions that include agents or compounds capable of modulating this inhibition. Furthermore, it outlines methods for enhancing T cell responses to tumors expressing pcdh18, such as adenocarcinoma, thereby providing potential benefits to patients.
Career Highlights
Alan B Frey is affiliated with New York University, where he continues to advance his research in immunology. His work has implications for developing new therapeutic strategies for cancer treatment, particularly in enhancing the immune response against tumors.
Collaborations
Some of his notable coworkers include Jeremy C Burns and Edwin J Vazquez-Cintron. Their collaborative efforts contribute to the ongoing research and development in the field of immunology.
Conclusion
Alan B Frey is a distinguished inventor whose work in modulating T cell effector function holds promise for improving cancer therapies. His innovative approaches and collaborations continue to impact the field significantly.